Hong Kong Stock Movement | GenFleet Therapeutics-B (02595.HK) rose nearly 4% in the afternoon; oral KRAS G12D inhibitor disclosed excellent clinical data.

Zhitong Finance APP has learned that GenFleet Therapeutics-B (02595.HK) rose nearly 4% in the afternoon session. As of press time, it was up 3.57% at HK$30.76, with a turnover of HK$93.7925 million.